Marketed By
Zeelab
Pack of
120 tablet(s) in a bottle
Salt Composition
Abiraterone Acetate
Storage
Keep in cold place
₹4522₹32812.50
86.22% Off
Tax: ₹542.64
1
Abritiga 250mg Tablet
Delivering To: —
Description
Abritiga 250mg tablet is widely used in the treatment of prostate gland in men, prescribed by healthcare professional. Its generic name is Abiraterone Acetate, taken in the form of 250mg tablet. The medication is used in the combination of chemotherapy and also given with steroid medications to lower the chances of side effects. The drug works by inhibiting the production of certain hormones that promote the growth of prostate cancer. Strict medical supervision is highly recommended while taking the medication.
Users and indications
Prostate gland cancer
Common side effects
Every medication shows several side effects, so patients should monitor their health and consult the doctor if any of these persist:
● Fatigue
● Vomiting
● Cough
● High blood pressure
● Headache
● Hot flashes
● Joint swelling
● Urinary tract infection
● Anemia
Dosage and administration
Abritiga 250mg tablet is taken orally twice a day with or without food to enhance the effectiveness of the treatment. Do not administer yourself; it should only be taken under the supervision of a healthcare professional as the doctor suggest the right dose according to patient health and response to the treatment.
Mechanism of action
Abiritiga 250mg tablet blocks the enzyme named CYP17 which is involved in the production of androgen hormones such as testosterone. By reducing testosterone levels, it helps stop the growth of certain cancer cells in the body. The tablet also limits the availability of nutrients that cancer cells need to grow and develop. Consultation is needed at the time of treatment.
Safety advice
Alcohol
unsafe
Alcohol is not good for health, taking it while using Abiritiga 250mg may reduce the effectiveness of the treatment. Avoid using it as it can interfere with therapy.
Driving
danger
Abritiga 250mg tablet does not affect the ability of driving, still if the patient feel dizziness during the treatment, avoid driving or operating heavy machinery.
Pregnancy
unsafe
Pregnant women should avoid Abritiga 250mg tablet as it harm the fetus.
Breast Feeding
consult your doctor
Abritiga 250mg tablet is not prescribed by healthcare professional without proper medical evaluation.
Kidney
caution
Doctors are not prescribed Abritiga 250mg tablet to kidney patients as it may worsen kidney function and cause harmful side effects.
Liver
unsafe
Abritiga 250mg tablet is not recommended for liver patients as it may increase the risk of liver damage.
FAQs
Abritiga 250mg tablet duration is depending on patient medical history and response to the treatment, consult the doctor about dosage and duration to ensure safety and effectiveness.
Abritiga 250mg tablet is taken by patient with advanced prostate cancer to help stop the growth of cancer cells, under the supervision of a doctor.
Yes, Abritiga 250mg tablet can be taken in combination of chemotherapy that help to enhance the quality of treatment.
Abritiga 250mg tablet helps the body to stop producing testosterone which is necessary for the growth of certain prostate cancer cells. So that cancer cannot grow. The medication is a hormonal therapy not chemotherapy, it helps to maintain the cancer growth but does not cure it permanently.
Abritiga 250mg tablet contain common and serious side effects as well, it is important to consult the doctor before using the medication.
Reference
• Thakur, A., Roy, A., Ghosh, A., Chhabra, M., & Banerjee, S. (2018). Abiraterone acetate in the treatment of prostate cancer. Biomedicine & Pharmacotherapy, 101, 211-218.
• Logothetis, C. J., Efstathiou, E., Manuguid, F., & Kirkpatrick, P. (2011). Abiraterone acetate. Nature Reviews Drug Discovery, 10(8), 573.
• Scott, L. J. (2017). Abiraterone acetate: a review in metastatic castration-resistant prostrate cancer. Drugs, 77(14), 1565-1576.
• Attard, G., Reid, A. H., A'Hern, R., Parker, C., Oommen, N. B., Folkerd, E., ... & de Bono, J. S. (2009). Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. Journal of clinical oncology, 27(23), 3742-3748.
Ratings And Reviews
4.60/5
5 Ratings
5 Star
60.00%
4 Star
40.00%
3 Star
0.00%
2 Star
0.00%
1 Star
0.00%
a year ago
a year ago
View All Reviews
Related Products
MARKETER DETAILS
Zeelab
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.